Navigation Links
Lo studio EXAMINE della Takeda sulla sicurezza cardiovascolare di alogliptin in aggiunta alla terapia standard ha soddisfatto l'endpoint primario di non inferiorità rispetto al placebo dimostrando che non si verifica nessun incremento del rischio ca
Date:9/17/2013

da termini previsionali quali "potere," "credere," "sarà," "aspettarsi," "proiettare," "stimare," "dovere," "anticipare," "pianificare," "ipotizzare," "continuare," "ricercare," "pro forma," "potenziale," "obiettivo," "previsioni," "direzione," "prospettive" o "avere intenzione" o locuzioni e termini simili comprese le forme negative di quanto sopra. Le dichiarazioni previsionali si basano su stime e ipotesi della direzione aziendale che si ritiene siano ragionevoli, sebbene siano per loro natura incerte e di difficile previsione. SI mettono in guardia gli investitori dal non fare eccessivamente affidamento su tali dichiarazioni previsionali.

Le dichiarazioni previsionali implicano rischi e incertezze che potrebbero determinare differenze sostanziali nei risultati effettivi o nella realtà dei fatti rispetto a quanto espresso o implicito in tali dichiarazioni previsionali. Alcuni di questi rischi e incertezze comprendono, ma non si limitano a ciò, (1) le condizioni economiche nelle quali opera Takeda, comprese le condizioni generale economiche in Giappone, negli Stati Uniti e nel mondo; (2) la pressione e gli sviluppi della concorrenza; (3) le norme e i regolamenti applicabili; (4) il successo o l'insuccesso dei programmi di sviluppo dei prodotti; (5) le azioni delle autorità normative e la loro tempistica; (6) cambiamenti dei tassi di cambio; (7) richieste di risarcimento o preoccupazioni relative alla sicurezza o all'efficacia dei prodotti commercializzati o dei prodotti candidati in sviluppo; e (8) le attività mirate all'integrazione con le società acquisite.

Le dichiarazioni previsionali riportate nel presente comunicato stampa sono valide esclusivamente alla data del presente comunicato e Takeda non assume alcun obbligo in merito alla loro revisione o aggiornamento in modo che riflettano nuove informazioni, eventi o circostanze future intervenute successivamente alla data delle dichiarazioni previsionali.
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Anthony Creed Joins DDSTUDIO As GM, Experience Design
2. Daiichi Sankyo ha completato larruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
3. Lo studio pubblicato su European Radiology esalta ulteriormente lutilizzo della tomosintesi al seno di Hologic nellambito dello screening del cancro con utilizzo della doppia lettura
4. I benefici della tecnologia Hologic per lutilizzo della Tomosintesi in vengono corroborati dalla pubblicazione di uno studio italiano
5. Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2
6. River City Laser Tattoo Removal Studio Offers Grand Opening Discounts on Treatments Using the Astanza Revolution Laser
7. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
8. New 2012 Cold Chain Report Examines the Extent of Temperature Excursions During the Handling of Temperature-Sensitive Pharmaceutical Shipments
9. Study Examines Smart Pharma Strategies for Effective Messaging around New Products and the Medical Conditions they Treat
10. TeamHealth White Paper Examines Telemedicine Risks, Risk Management Strategies
11. The Food Journal Examines Dietary Supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ALISO VIEJO, Calif. , June 30, 2015 ... from the PRISM II study showing that treatment ... statistically significant reduction in symptoms of pseudobulbar affect ... or stroke. PBA is a distressing condition characterized ... crying resulting from certain neurologic diseases or brain ...
(Date:6/30/2015)... – Small Cap IR issues report. Recently, Arrayit Corporation ... blood card technology to Vivos, Global Genome Vault, the ... an impervious, impenetrable and permanent DNA storage vault, able ... Earth, a safe and secure nuclear blast-proof, underground shelter ... rapid collection, separation, drying and storage of human genomic ...
(Date:6/30/2015)... 2015  Egalet Corporation (Nasdaq: EGLT ... company focused on developing, manufacturing and marketing ... from a Category 3 human abuse liability ... oral oxycodone product candidate in late-stage clinical ... enough to require daily, around-the-clock opioid treatment ...
Breaking Medicine Technology:Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7Small Cap IR - Empowering the Age of Genetic Enlightenment 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5
... Technologies, Inc. (NYSE Amex: PTN ), ... for the treatment of diseases with significant unmet ... Dr. Carl Spana, President and Chief Executive Officer ... Eighth Annual Equity Conference.  The presentation is scheduled ...
... YORK, Jan. 16, 2012 Reportlinker.com announces ... available in its catalogue: , ... http://www.reportlinker.com/p0760637/Pharmaceutical-MA-in-the-Asia-Pacific-Region.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical ... continues in major developed markets, prompted by ...
Cached Medicine Technology:Palatin Technologies to Present at BOCEMb, Noble Financial Capital Markets' Eighth Annual Equity Conference 2Pharmaceutical M&A in the Asia Pacific Region 2Pharmaceutical M&A in the Asia Pacific Region 3Pharmaceutical M&A in the Asia Pacific Region 4
(Date:6/30/2015)... Diego, California (PRWEB) , ... June 30, 2015 , ... ... Solar Power today at a media event in San Diego. Speakers and clean air ... Diego School of medicine, Natalie Germuska of Kindred Hospital, and Daniel Sullivan, founder and ...
(Date:6/30/2015)... CA (PRWEB) , ... June 30, 2015 , ... According ... has received a $3.1 million grant to study how sensory stimuli can be used ... special emphasis on improving care for children with autism, will compare patient experience in ...
(Date:6/30/2015)... ... June 30, 2015 , ... After many requests from ... its here, http://www.express-glasses.com is proud to announce its collaboration with DHL ... shipping with DHL Express when calling or visiting the express glasses website. express ...
(Date:6/30/2015)... ... June 30, 2015 , ... Rocky Mountain Oils, a leading non-MLM ... team and added a new CEO, Mr. Darold Francis. The changes will help enhance ... essential oils that customers have come to know and respect for over eight years. ...
(Date:6/30/2015)... Parsippany, NJ (PRWEB) , ... June 30, 2015 ... ... as executive vice president and general manager of HRA Healthcare Research & ... Plainsboro, N.J.-based Michael J. Hennessy Associates, Inc. (MJH) family of businesses. HRA offers ...
Breaking Medicine News(10 mins):Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3Health News:Eyeglasses Online - Express Glasses Announcing New International Shipping Using DHL 2Health News:Rocky Mountain Oils Adds New CEO, Announces Relocation of Operations to Orem, Utah 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 3
... Seek Vote to Join More Than 55,000 Others Who Have ... Calif., Jan. 8 /PRNewswire-USNewswire/ -- Healthcare ... elections to join more than 55,000 other union members who ... International Union - United Healthcare Workers West (SEIU-UHW), rather than ...
... Quercetin , FRIDAY, Jan. 8 (HealthDay News) -- Researchers ... in hepatitis C infection, and they say the finding may ... which can lead to cirrhosis and liver cancer. , The ... can cause major side effects and aren,t effective in all ...
... of uridine, choline and DHA boosted memory of Alzheimer,s patients ... A combination of three nutrients might help improve memory in ... (synapses), a new study shows. , Uridine, choline and the ... precursors to the fatty molecules that make up brain cell ...
... , , - Subtle ... , PHILADELPHIA, Jan 8 Children with autism spectrum disorders (ASDs) ... children without ASDs, and measuring magnetic signals that mark this delay ... http://www.newscom.com/cgi-bin/prnh/20100108/DC34671 ) , Researchers at The Children,s Hospital ...
... Jan. 8 Gilbert Hospital expects patient volume at its ... and continued easing of the nationwide economic unrest have officials ... this community-based hospital. , "We are expecting smaller growth and ... east valley, but the state and the nation," said Randy ...
... , GILBERT, Ariz., Jan. 8 Gilbert Hospital continued ... patient visits through the emergency department, patient levels remained constant ... Doc in 31 Minutes" continued its success with more than ... certified physician within 31 minutes of arrival. Additionally, the average ...
Cached Medicine News:Health News:SEIU-UHW Members at 26 Hospitals and Nursing Homes Seeking Elections Against Group Started by the Union's Ousted Leaders 2Health News:SEIU-UHW Members at 26 Hospitals and Nursing Homes Seeking Elections Against Group Started by the Union's Ousted Leaders 3Health News:Key to Hepatitis C May Be Two Cellular Proteins 2Health News:Brain Imaging May Help Diagnose Autism 2Health News:Brain Imaging May Help Diagnose Autism 3Health News:Brain Imaging May Help Diagnose Autism 4Health News:Gilbert Hospital Forecasts Steady 2010 2Health News:Gilbert Hospital 2009 Emergency Department Year in Review 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: